Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare logo
$208.96 -7.68 (-3.55%)
Closing price 10/23/2026 03:59 PM Eastern
Extended Trading
$209.16 +0.20 (+0.09%)
As of 10/23/2026 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Molina Healthcare - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
2
Hold
13
Buy
3

Based on 18 Wall Street analysts who have issued ratings for Molina Healthcare in the last 12 months, the stock has a consensus rating of "Hold." Out of the 18 analysts, 2 have given a sell rating, 13 have given a hold rating, and 3 have given a buy rating for MOH.

Consensus Price Target

$209.63
0.32% Upside
According to the 18 analysts' twelve-month price targets for Molina Healthcare, the average price target is $209.63. The highest price target for MOH is $286.00, while the lowest price target for MOH is $124.00. The average price target represents a forecasted upside of 0.32% from the current price of $208.96.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for MOH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Molina Healthcare and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MOH Analyst Ratings Over Time

TypeCurrent Forecast
10/25/25 to 10/25/26
1 Month Ago
9/25/25 to 9/25/26
3 Months Ago
7/27/25 to 7/27/26
1 Year Ago
10/25/24 to 10/25/25
Strong Buy
0 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
Hold
13 Hold rating(s)
11 Hold rating(s)
11 Hold rating(s)
10 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$209.63$202.44$203.38$203.64
Forecasted Upside0.32% Upside6.12% Upside1.76% Upside24.81% Upside
Consensus RatingHoldHoldHoldHold

MOH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MOH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Molina Healthcare Stock vs. The Competition

TypeMolina HealthcareHealthcare CompaniesBroader Market
Consensus Rating Score
2.06
2.32
2.53
Consensus RatingHoldHoldModerate Buy
Predicted Upside0.32% Upside1,400.11% Upside16.92% Upside
News Sentiment Rating
Neutral News

See Recent MOH News
Neutral News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/23/2026
Ben Hendrix
Ben Hendrix
3 of 5 stars
Boost TargetSector Perform$218.00 ➝ $222.00+6.05%
10/23/2026
Robert W. Baird logo
Robert W. Baird
3 of 5 stars
Michael Ha
Michael Ha
3 of 5 stars
Set Target$198.00-5.42%
10/23/2026
UBS Group AG logo
UBS Group
4 of 5 stars
A.J. Rice
A.J. Rice
4 of 5 stars
Boost TargetNeutral$202.00 ➝ $225.00+3.90%
10/23/2026Lower TargetUnderweight$180.00 ➝ $178.00-17.80%
10/23/2026Set Target$255.00+17.76%
10/23/2026Reiterated RatingHold$220.00+1.59%
10/23/2026Boost TargetEqual Weight$167.00 ➝ $192.00-10.10%
10/21/2026 UpgradeSell (D) ➝ Sell (D+)
10/12/2026 DowngradeStrong-Buy ➝ Hold
10/9/2026Reiterated RatingNeutral
7/28/2026Lower TargetEqual Weight$235.00 ➝ $220.00+10.07%
7/24/2026Lower TargetHold$250.00 ➝ $225.00+15.42%
7/14/2026Boost TargetHold$163.00 ➝ $230.00-5.48%
7/13/2026 Set Target$286.00+19.75%
6/8/2026Boost TargetNeutral$169.00 ➝ $191.00-2.77%
4/29/2026 UpgradeUnderperform ➝ Buy$250.00+34.76%
4/24/2026 Reiterated RatingHold$129.00-23.33%
2/11/2026Lower TargetNeutral$167.00 ➝ $124.00+1.10%
4/9/2025Initiated CoverageNeutral
2/6/2025Reiterated RatingEqual Weight$345.00 ➝ $345.00+19.20%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 04:30 PM ET.


Should I Buy Molina Healthcare Stock? MOH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, October 22, 2026. Please send any questions or comments about these Molina Healthcare pros and cons to contact@marketbeat.com.

Molina Healthcare
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Molina Healthcare, Inc.:

  • Molina Healthcare, Inc. recently beat third-quarter earnings estimates by reporting adjusted earnings per share of $0.89, which exceeded the consensus estimate of $0.79, demonstrating the company's ability to outperform market expectations despite a challenging medical cost environment.
  • The company has outlined preliminary 2027 earnings building blocks exceeding $9.50 per share, which is supported by anticipated Medicaid rate increases of about 6%, the maturation of new contracts, and the planned exit from its Medicare Advantage prescription drug business, providing a clear path for future profitability.
  • Molina Healthcare, Inc. is currently trading at $216.55, a price that reflects a significant recovery from its 52-week low of $121.06, indicating strong investor confidence in the company's operational improvements and strategic positioning in the managed care sector.
  • The company's legacy Medicaid business is expected to produce a 1.6% pretax margin for 2026, with management indicating that the business is at the low point of a multiyear margin cycle, suggesting that future rate updates and cost trend adjustments could lead to improved profitability in subsequent years.
  • Molina Healthcare, Inc. has successfully implemented its new Florida CMS contract, taking on 115,000 members with an annualized revenue run rate of about $6 billion, which is expected to improve to breakeven or better in 2027 after an initial earnings drag in 2026.

Molina Healthcare
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Molina Healthcare, Inc. for these reasons:

  • The company is facing a $1.50-per-share earnings drag in 2026 due to the implementation of its new Florida CMS contract, which includes a roughly 99% medical care ratio and a 5% pretax loss in the fourth quarter, weighing on near-term profitability.
  • Molina Healthcare, Inc. expects a 6% membership decline in 2027 due to federal work requirements and more frequent eligibility reverifications, which could reduce premium revenue and impact the company's overall financial performance.
  • The company's Medicare Advantage prescription drug business is projected to lose $1 per share in 2026 before Molina exits that product line in 2027, representing a significant financial burden that will not be resolved until the planned exit is completed.
  • Molina Healthcare, Inc. has raised its medical-cost trend assumption to 5.5% for 2026, reflecting elevated utilization in several care categories and a modest shift in member acuity, which could pressure margins and reduce the company's ability to generate profits.
  • The company's full-year 2027 premium revenue outlook has been reduced to at least $45 billion from an earlier outlook of $46.5 billion, due to delayed implementation of Medicaid contracts in Georgia and Texas, which together account for $1.3 billion of premium revenue and are currently being evaluated in state court.

MOH Forecast - Frequently Asked Questions

According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Molina Healthcare is $209.63, with a high forecast of $286.00 and a low forecast of $124.00.

18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Molina Healthcare in the last year. There are currently 2 sell ratings, 13 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MOH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MOH, but not buy additional shares or sell existing shares.

According to analysts, Molina Healthcare's stock has a predicted upside of 0.32% based on their 12-month stock forecasts.

Over the previous 90 days, Molina Healthcare's stock had 4 downgrades and 3 upgrades by analysts.

Analysts like Molina Healthcare less than other "healthcare" companies. The consensus rating score for Molina Healthcare is 2.06 while the average consensus rating score for "healthcare" companies is 2.32. Learn more on how MOH compares to other companies.


MarketBeat monitors more than a dozen sources for Molina Healthcare analyst ratings, with the most recent rating issued on 10/23/2026.
From Our Partners